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Abstract 
 
Background and Aims: Prolonged endurance exercise over several days induces increases of 
extracellular water (ECW). We aimed to investigate an association between the increase in 
ECW and the change in aldosterone and vasopressin in a multi-stage ultra-endurance 
triathlon, the ‘World Challenge Deca Iron Triathlon’ with 10 Ironman triathlons within 10 
days. Methods: Before and after each Ironman, body mass, ECW, urinary [Na+], urinary 
[K+], urinary specific gravity urinary osmolality and aldosterone and vasopressin in plasma 
were measured. Results: The 11 finishers completed the total distance of 38 km swimming, 
1,800 km cycling and 422 km running within 145.5 (18.8) h and 25 (22) min. ECW increased 
by 0.9 (1.1) L from 14.6 (1.5) L pre race to 15.5 (1.9) L post race (p < 0.0001). Aldosterone 
increased from 70.8 (104.5) pg/mL to 102.6 (104.6) pg/mL (p = 0.033), vasopressin remained 
unchanged. The increase in ECW was neither related to post race aldosterone nor to post race 
vasopressin. The changes in aldosterone and vasopressin were not related to the increase in 
ECW. Conclusions: ECW and aldosterone increased after this multi-stage ultra-endurance 
triathlon, but not vasopressin. The increase in ECW and the increase in aldosterone were not 
associated.  
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Introduction 
 
Long-distance triathlons such as the Ironman triathlon are highly popular and are held since 
the first event in 1978 in Hawaii.1 In 2006, for the first time, a multi-stage long-distance 
triathlon was held in Mexico, where athletes had to complete one Ironman distance per day 
for 10 days.2  
 
In single Ironman triathlons, exercise-associated hyponatremia (EAH) is considered a 
frequent and serious problem.3,4 EAH is defined as a decrease in plasma [Na+] concentration < 
135 mmol/l 5 and fluid overload is the likely aetiology.4,6 However, regarding recent findings, 
an increased activity of vasopressin may contribute to the pathogenesis of EAH in runners.7,8    
 
An interesting finding in multi-stage ultra-endurance performances is the increase in total 
body water.9,10 It has been well documented that prolonged strenuous exercise over several 
consecutive days induced a progressive increase in extracellular water, plasma volume and 
total body water. 11-15 Sodium retention seemed to be the major factor in the increase in 
plasma volume.9 In multi-stage ultra-endurance runs, plasma volume increased,13-15 plasma 
[Na+] concentration was maintained 15,16 and aldosterone increased.13,14 Presumably fluid 
homeostasis during an ultra-endurance performance is regulated by both aldosterone and 
vasopressin.  
 
Also for Ironman triathletes, in increase in plasma volume has been described.4,17 Ironman 
triathletes with symptomatic EAH showed abnormal fluid retention with an increased 
extracellular volume.4 Fluid retention, however was not associated with an increased activity 
of vasopressin in Ironman triathletes.4  
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The association of vasopressin with effect on renal function and association with EAH has 
been investigated in marathon runners. 18 Marathon runners developing EAH showed an 
increase in body mass 19,20 and it was assumed that inappropriate anti-diuretic hormone release 
during exercise altered renal function 20 which may lead to water retention and EAH21. 
 
The aim of this study was to investigate the association between the increase in both total 
body water and extracellular water with changes in both aldosterone and vasopressin during a 
multi-stage ultra-endurance triathlon, in order to determine whether the increase in total body 
water and extracellular water would be related to an increased activity in aldosterone or in 
vasopressin. We hypothesised that both vasopressin and aldosterone would be increased after 
a multi-stage ultra-endurance race, and that rather the increase in aldosterone would be related 
to the increase in both total body water and extracellular water than the increase in 
vasopressin. 
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Materials and Methods 
 
Subjects 
The organiser of the ‘World Challenge Deca Iron Triathlon’ in the 2009 edition contacted all 
participants via a asking them to participate in the study. The study was approved by the 
Ethical Committee of St. Gallen, Switzerland. All participants were informed about the 
experimental procedures and gave their informed written consent. All 17 participating athletes 
were interested and took part in the investigation. Of the 17 starters, 11 athletes with (mean 
and SD) 44.0 (10.5) years, 76.0 (7.3) kg body mass, 1.73 (0.06) m body height and a body 
mass index of 25.4 (2.0) kg/m2 finished the race and were included in the study. 
    
The race 
The ‘World Challenge Deca Iron Triathlon’ was held in 2009 for the third time. The 
competition took place in the City of Monterrey in the Province of Nuevo León in northern 
Mexico. The race started on 9 November 2009. Seventeen male, and one female, ultra-
endurance triathletes entered the race. Every day they had to complete the distance of one 
Ironman triathlon of 3.8 km swimming, 180 km cycling and 42.195 km running with a time 
limit of 24 hours. Every morning at 09:00 the event started with the swim in the 25 m indoor 
pool at the ‘Centro Acuatico Olimpico Universitario’ of ‘Universidad Autonoma de Nuevo 
Leòn’ in Monterrey. The pool was heated and held at a constant temperature of 28 °Celsius. 
Laps of 25 m were counted by personal lap counters. After completing the swim, the athletes 
changed in the transition area and cycled to the ‘Parque Niños Héroes’. This park was closed 
to traffic, completely illuminated and had a cycling track that was 95% flat, but included an 
inclination of 5%. The cycling consisted of 94 laps of 1.915 km each. After changing for the 
running course, the athletes first had to run a short lap of 703 m and then 22 laps of 1.886 km. 
In total, the athletes had to climb an altitude of 1,650 m per Ironman triathlon. Drafting during 
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cycling was strictly prohibited. Laps in the cycling and running course were counted 
electronically with a chip system. Athletes could be helped by their own support crew for 
nutrition and changes of equipment and clothes. During the whole race, accommodation was 
offered in the ‘Parque Niños Héroes’. The athletes and their support crew had a room with 
bed, toilet and shower. For nutrition, the organiser offered a variety of food in a restaurant 
that was open 24 h. 
 
Analysis of body composition 
Before and after each stage, body composition was measured using the InBody 3.0 body 
composition analyser with direct segmental multifrequency bioelectrical impedance method 
(InBody 3.0, Biospace, Seoul, Korea) following Bedogni et al.22 This method is reliable for 
determination of body water under both laboratory situations22 and field conditions.9 
However, hydration status must be unchanged 23 and extracellular osmolality must be stable24. 
InBody 3.0 has a tetrapolar 8-point tactile electrode system and performs 20 impedance 
measurements at each session, using four different frequencies (5 kHz, 50 kHz, 250 kHz, and 
500 kHz) at each of five segments (right arm, left arm, trunk, right leg, and left leg). The 
subjects stood barefoot in an upright position on foot electrodes, with the legs and thighs not 
touching and the arms not touching the torso. Four foot electrodes were used and the subjects 
were asked to grip the two palm-and-thumb electrodes. They did this without shoes or excess 
clothing. The skin and electrodes were cleaned and dried before testing. Body mass, lean 
body mass, total body water, intracellular water, extracellular water, fat mass, and protein 
mass were directly determined. 
 
Laboratory analysis 
Before the start of the race, aldosterone and vasopressin were determined at rest. After 
venipuncture of an antecubital vein, the blood was centrifuged at 3,000 g for 10 min at 4 
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°Celsius; the serum was then separated, stored on ice, and then processed to determine both 
aldosterone and vasopressin using a radioimmunoassay method. The radioimmunoassay 
method measured quantitatively the concentration of aldosterone in the blood within a 
reference range of 10.0 pg/mL to 300 pg/mL, the activity of vasopressin within a reference 
range of 1.0 μU/mL to 2.0 μU/mL. The same procedure was repeated immediately upon 
arrival at the finish line after the last Stage on Day 10. Immediately before and immediately 
after each stage, samples of urine were collected. In the urine samples, [Na+], [K+], specific 
gravity and osmolality were determined. [Na+] and [K+] were determined using an ion 
selective electrode method. Specific gravity was measured manually using a NE Uricon 
refractometer which has a scale from 1,000 g/mL to 1,050 g/mL. To determine osmolality, 
urea was measured in the urine samples using a HITACHI 911 automated equipment using an 
enzymatic method; the formula urinary osmolality = (Na + K x 2) + urea/5.6 was used to 
calculate osmolality with a reference range of 300 mosm/kg to 1,000 mosm/kg. 
 
Statistical analysis 
For finishers and non-finishers, overall changes of the variables over time were tested by 
MANOVA-procedure. In case of a significant change during the race paired t-tests were 
applied to detect a significant change from one time period to the other. For non-finishers, 
paired-t-tests were applied to detect changes from one time period to the other as long as the 
athlete was in the race and had completed a full stage. For finishers, Pearson correlation 
analysis was used to check for associations between parameters with statistically significant 
changes. Statistical significance was accepted with p < 0.05. 
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Results 
 
Performance 
A total of 17 male competitors started on 9 November 2009; six athletes did not reach the 
finish line. The first non-finisher dropped out on day 1 due to an accident, the second non-
finisher stopped after day 2 due to overuse injuries of the lower limbs. After day 3, the third 
non-finisher stopped due to loss of motivation and the fourth non-finisher withdrew due to 
fatigue and overuse injuries of the lower limbs. On day 4, the fifth non-finisher had to stop 
due to respiratory problems and on day 5, the sixth non-finisher resigned due to fatigue and 
overuse injuries of the lower limbs. The 11 finishers completed the total distance of 38 km 
swimming, 1,800 km cycling and 422 km running within 145.5 (18.8) h and 25 (22) min, 
equal to 8,757 (1,129) min. Table 1 represents the daily total race times per Ironman distance 
and the daily highest temperature. The time per Ironman increased throughout the race (p < 
0.0001) (see Figure 1); the daily highest temperature was not related to the daily race time. 
 
Changes in body composition during the race 
For finishers, body mass decreased by 1.7 (2.4) kg from 76.3 (7.7) kg pre race to 74.6 (7.1) kg 
post race (p < 0.0001) (see Figure 2). Fat mass decreased by 3.2 (1.6) kg from 13.1 (4.0) kg 
pre race to 10.1 (3.6) kg post race (p < 0.0001). The decrease in body mass was significantly 
and positively related to the decrease in fat mass (r = 0.71, p = 0.022). Race time was neither 
correlated to pre race body mass nor to pre race fat mass. Lean body mass increased by 1.1 
(2.5) kg from 62.9 (4.6) kg pre race to 64.0 (6.5) kg post race (p < 0.01). Protein mass showed 
no changes. Total body water increased by 1.5 (1.6) L from 46.3 (3.5) L pre race to 47.8 (4.1) 
L post race (p < 0.0001) (see Figure 3). Extracellular water increased by 0.9 (1.1) L from 
14.6 (1.5) L pre race to 15.5 (1.9) L post race (p < 0.0001). Intracellular water showed no 
changes. The increase in total body water was related to the increase in extracellular water (r 
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= 0.64, p = 0.047). The increase in lean body mass was neither correlated to the increase in 
total body water (r = -0.36, p = 0.33) nor to the increase in extracellular water (r = -0.36, p = 
0.33). Post race lean body mass was highly significantly correlated to both post race total 
body water (r = 0.94, p < 0.0001) and to post race extracellular water (r = 0.81, p = 0.0044). 
 
Changes in urinary parameters, aldosterone and vasopressin 
Urinary [Na+] showed no changes (see Figure 4), urinary [K+] and the potassium-to-sodium 
ratio in urine increased (p < 0.0001) for finishers. Urinary specific gravity and urinary 
osmolality showed no changes. Aldosterone increased from 70.8 (104.5) pg/mL pre race to 
102.6 (104.6) pg/mL post race (p = 0.033); vasopressin remained unchanged at 1.34 (0.46) 
μU/mL pre race to 1.68 (0.73) μU/mL post race (p = 0.252). The change in aldosterone and 
the change in and the potassium-to-sodium ratio in urine were not associated (r = -0.40, p = 
0.28), also post race aldosterone and post race potassium-to-sodium ratio in urine showed no 
association (r = 0.05, p = 0.89). The change in vasopressin was not related to the change in 
urinary osmolality (r = -0.22, p = 0.59) and post race vasopressin was not associated to post 
race urinary osmolality (r = 0.10, p = 0.80). The increase in extracellular water was neither 
related to post race aldosterone (r = -0.36, p = 0.33) nor to post race vasopressin (r = -0.33, p 
= 0.38). The changes in aldosterone (r = -0.32, p = 0.40) and vasopressin (r = -0.28, p = 0.47) 
were not related to the increase in extracellular water. Post race extracellular water was 
neither related to post race aldosterone (r = -0.40, p = 0.28) nor to post race vasopressin (r = -
0.26, p = 0.49). 
 
Results of the non-finishers 
Table 2 represents the results of the non-finishers. After three stages, four non-finishers were 
still in the race. Body mass and fat mass decreased significantly whereas total body water and 
extracellular water showed no changes. While urinary sodium and urinary potassium 
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remained stable, the potassium-to-sodium ratio increased. Urinary specific gravity and urinary 
osmolality showed no changes. 
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Discussion 
 
The aim of this study was to investigate the association between the increase in both total 
body water and extracellular water with changes in both aldosterone and vasopressin in a 
multi-stage ultra-endurance triathlon, in order to determine whether the increase in total body 
water and extracellular water would be related to an increased activity in aldosterone or in 
vasopressin.  
 
A first hypothesis was that aldosterone would be increased after this multi-stage ultra-
endurance triathlon. In line with our hypothesis, serum aldosterone increased significantly 
from 70.8 (104.5) ng/dL pre race to 102.6 (104.6) ng/dL post race. We see the increase in the 
potassium-to-sodium ratio as being due to an increased activity of aldosterone. The 
potassium-to-sodium ratio in urine was < 1.0 before the start of the race and increased to > 1.0 
after Day 1 and before and after Day 2. This suggests that during this time more potassium 
than sodium was excreted through the kidney, and a positive ratio for potassium-to-sodium in 
urine suggests an increased activity of aldosterone. We interpret the increase in urinary 
potassium as a reaction to a stimulation of the renin-angiotensin-aldosterone-system (RAAS). 
This suggests that during these days more potassium than sodium was excreted through the 
kidneys and a positive ratio for potassium to sodium in urine suggests an increased activity of 
aldosterone. A potassium-to-sodium ratio in urine > 1.0 reflects a contraction of the effective 
extra-cellular volume leading to a hyperreninemic hyperaldosteronemia. The potassium-to-
sodium ratio in urine is a physiological reflection of the potassium excretion in the distal 
tubulus and in comparison to the sodium re-absorption, an estimate of aldosterone activity in 
serum. This is also backed up by the increased activity of aldosterone post race. In the first 
two days, the potassium-to-sodium ratio was > 1.0 and we must assume that aldosterone 
activity was higher in these days compared to the rest of the race since the RAAS-axis is 
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stimulated in an intensity-dependent fashion.25 This might also be backed up with the faster 
stages times in the beginning of the race and the finding, that both post race aldosterone and 
the change in aldosterone were not related to both the post race potassium-to-sodium ratio and 
the change in potassium-to-sodium ratio in urine. The timeframe over ten days was probably 
too long that aldosterone would have been increased highly enough. 
 
A second hypothesis was that the increase in aldosterone would be related to the increase in 
extracellular water. Although extracellular water increased, the increase in extracellular water 
was neither related to both post race serum aldosterone nor to the change in serum 
aldosterone. Speedy et al. measured both vasopressin and aldosterone in five subjects and 11 
controls after an Ironman triathlon.4 The median post race aldosterone in the subjects did not 
differ significantly from the controls. They found no evidence that aldosterone contributed to 
fluid retention. Regarding recent findings, an increased activity of vasopressin may contribute 
to the pathogenesis of EAH.7,8 However, vasopressin showed no change in this race and the 
increase in extracellular water was neither related to post race vasopressin nor to the change in 
vasopressin. Likewise, vasopressin and urinary osmolality showed no relationship. Speedy et 
al. measured vasopressin in addition to aldosterone in their subjects and controls after an 
Ironman triathlon.4 The median post race vasopressin was significantly lower in the subjects 
compared to the controls. They concluded that fluid retention was not due to vasopressin. 
Also, already 30 years ago, Williams et al. found during a multi-stage performance an 
increase in plasma volume, but no increase in vasopressin.14 One problem in the 
determination of the activity of vasopressin during a field study is its short half life time of 
24.1 min.26 Considering that the athletes got slower and slower during the race, the activity of 
vasopressin will also be reduced. The fastest Ironman was on Day 1, the slowest Ironman was 
on Day 9. This might also explain why vasopressin was not increased post race since 
vasopressin release is intensity dependent.27 There is also a delay between the arrival at the 
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finish line and the blood sampling under field conditions.4  The determination of Copeptin as a 
stable peptide and precursor of vasopressin might be more useful to detect hormonal 
changes.28-30 
 
Another problem regarding the determination of the fluid retention could be the applied 
method of bioelectrical impedance analysis. We measured total body water, extracellular 
water and intracellular water using the bioelectrical impedance analysis method. This method 
is reliable under both laboratory situations22 and field conditions.9 However, hydration 
status23 and extracellular osmolality24 must be stable. In our athletes, urinary specific gravity, 
urinary osmolality and urinary sodium remained unchanged throughout the race. Since 
urinary indices are reliable indices of hydration status 31 with urine osmolality as the most 
promising marker available,32 we consider the results of bioelectrical impedance analysis for 
both total body water and extracellular water reliable. In a recent study in a multi-stage 
mountain bike race, the time course of the decrease in body mass and the increase in 
extracellular water could be described in the same manner using the same method.11 In 
another recent study in a multi-stage cycling race, an increase in lean body mass was 
described while using dual energy x-ray absorptiometry.33 The meaning of this increase in 
lean body mass remains unclear, and the development of an oedema might be postulated.34 
However, we found no association between the increase in lean body mass and the increase in 
both total body water (r = -0.36, p = 0.33) and extracellular water (r = -0.36, p = 0.33). 
 
One might assume that the non-finishers may have dropped out due to disorders in fluid and 
electrolyte metabolism since EAH in Ironman triathletes may amount to ~18%.35 However, 
EAH in Ironman triathletes is usually asymptomatic 35 and the non-finishers in this race gave 
up due to accident (1), overuse injuries of the lower limbs (1), fatigue and overuse injuries of 
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the lower limbs (2), respiratory problems (1), and loss of motivation (1). These symptoms 
were not typical for EAH.5 
 
This investigation is limited in that haemoglobin, haematocrit, plasma sodium and plasma 
potassium were not determined before and after each stage in order to show changes between 
performance and recovery. Also the data of fluid intake and urinary output would give more 
insight into fluid regulation.11 In athletes at the edge of physical performance and without a 
support crew; however, it is not possible to burden them unnecessarily. The non-invasive 
investigation such as measuring body composition using bioelectrical impedance analysis2 
and urinary analysis36 takes little time per day, does not bother ultra-endurance athletes while 
racing and resting, and provides reliable data. However, analysis of haemoglobin, haematocrit 
and plasma electrolytes could be performed in ultra-endurance athletes using a point-of-care 
(POC) analyzer such as the i-STAT ,37 where only capillary samples would be needed.38 
 
To summarise, we found an increase in aldosterone and extracellular water after this multi-
stage ultra-endurance triathlon. However, we could not establish an association between the 
increase in extracellular water and the increase in aldosterone. Furthermore, we found neither 
an increase in vasopressin, nor an association between both the change in vasopressin and 
post race vasopressin with the increase in extracellular water. The increase in total body water 
and extracellular water could not be explained by hormonal changes. In future studies, the 
marker Copeptin should be determined as a stable peptide and precursor of vasopressin that 
might be more useful to detect hormonal changes during ultra-endurance performance and a 
potential association between the increase in extracellular water and hormonal changes. Renal 
function might have changed during these 10 days and excretion of water might have been 
reduced. Furthermore, intake of fluid during the heat of the day might have led to fluid 
overload. 
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Day Finish time (min) Temperature (°C) 
1 760 (106) 27 
2 849 (166) 26 
3 815 (95) 28 
4 855 (108) 27 
5 897 (133) 29 
6 882 (127) 31 
7 906 (119) 31 
8 889 (139) 23 
9 953 (155) 19 
10 940 (203) 23 
 
Table 1: Daily finish times per Ironman distance and daily highest temperature. Race times 
are presented as mean (SD). 
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Parameter Before  
stage 1 
(n=5) 
After 
stage 1 
(n=5) 
Before 
stage 2  
(n=4) 
After 
stage 2 
(n=4) 
Before 
stage 3 
(n=4) 
After 
stage 3 
(n=4) 
Body mass (kg) 76.6 (5.7) 72.7 (4.9) $, * 74.0 (5.2) $ 72.8 (5.1) $, * 73.1 (4.6) $, * 72.2 (4.6) $ 
Fat mass (kg) 11.1 (2.7) 8.6 (1.9) 10.7 (1.9) $ 8.8 (1.0) $ 10.7 (0.9) $, * 9.7 (1.3) $, * 
Lean body mass (kg) 65.6 (5.0) 64.1 (3.3) 63.3 (5.1) 64.0 (4.6) 62.4 (5.1) 62.6 (5.3) 
Protein mass (kg) 13.1 (0.9) 12.9 (0.7) 12.8 (1.0) 12.9 (1.0) 12.5 (1.0) 12.5 (1.0) 
Total body water (L) 48.4 (3.8) 47.2 (2.5) 46.5 (3.8) 47.1 (3.5) 46.0 (3.8) 46.1 (4.0) 
Extracellular water (L) 15.6 (1.5) 14.8 (0.9) 14.5 (1.4) 14.7 (1.2) 14.7 (1.4) 14.8 (1.5) 
Intracellular water (L) 32.8 (2.3) 32.4 (1.7) 32.0 (2.5) 32.4 (2.4) 31.3 (2.4) 31.3 (2.5) 
Urinary sodium (mg) 176.4 (43.1) 95.8 (46.0) 83.4 (30.5) 82.8 (15.7) 102.5 (41.0) 116.3 (44.4) 
Urinary potassium (mg) 73.6 (72.9) 132.4 (57.3) 51.5 (14.8) 135.1 (51.8) 43.1 (11.4) 137.2 (38.7) 
Potassium-to-sodium ratio 0.50 (0.65) 1.61 (0.92) 0.70 (0.40) 1.60 (0.43) $ 0.49 (0.27) * 1.36 (0.75) 
Urinary specific gravity (g/mL) 1.016 (0.004) 1.028 (0.004) 1.025 (0.004) 1.030 (0.001) 1.034 (0.004) 1.022 (0.010) 
Urinary osmolality (mosmoL/kg) 746.3 (146.4) 940.4 (177.3) 909.5 (134.9) 1,086.3 (203.4) 1,016.9 (179.7) 1,138.1 (143.0) 
 
Table 2: Results of the non-finishers were only included when an athlete finished the stage and results from both pre and post stage were available. 
Results are expressed as mean (SD). $ = p < 0.05 versus baseline value. * = p < 0.05 versus previous value.
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Figure 1: Daily finish times throughout the race. Time per Ironman increased significantly 
throughout the race (p < 0.0001). 
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Figure 2: Changes in body mass (BM), fat mass (FM), lean body mass (LBM) and protein 
mass (PM) during the 10 days. $ = p < 0.05 versus baseline value. * = p < 0.05 versus 
previous value.  
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Figure 3: Changes in total body water (TBW), extracellular water (ECW) and intracellular 
water (ICW) during the 10 stages. $ = p < 0.05 versus baseline value. * = p < 0.05 versus 
previous value.  
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Figure 4: Changes in urinary sodium (urine Na), urinary potassium (urine K), the potassium-
to-sodium ratio (K/Na), urinary specific gravity (USG) and urinary osmolality (osmo) during 
the 10 days. $ = p < 0.05 versus baseline value. * = p < 0.05 versus previous value.  
 
